NEW YORK (GenomeWeb News) - Belgian company OncoMethylome Sciences has expanded its lab in Amsterdam by leasing an extra 1,000 square meters of lab space and hiring 10 new scientists.
 
The company said it expanded operations and personnel to support clinical trials for the its colorectal cancer program.
 
OncoMethylome is developing non-invasive molecular methylation screening tests that are performed on DNA from blood or stool samples. The research is supported by the Dutch Ministry of Economic Affairs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.